371 related articles for article (PubMed ID: 11197445)
1. Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention Project.
de Gaetano G;
Lancet; 2001 Jan; 357(9250):89-95. PubMed ID: 11197445
[TBL] [Abstract][Full Text] [Related]
2. Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial.
Sacco M; Pellegrini F; Roncaglioni MC; Avanzini F; Tognoni G; Nicolucci A;
Diabetes Care; 2003 Dec; 26(12):3264-72. PubMed ID: 14633812
[TBL] [Abstract][Full Text] [Related]
3. Epidemiological feasibility of cardiovascular primary prevention in general practice: a trial of vitamin E and aspirin. Collaborative group of the Primary Prevention Project.
J Cardiovasc Risk; 1995 Apr; 2(2):137-42. PubMed ID: 7606650
[TBL] [Abstract][Full Text] [Related]
4. [The Primary Prevention Project Study Group. Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomized trial in general practice].
De Caterina R
Ital Heart J Suppl; 2001 Jun; 2(6):681-4. PubMed ID: 11460845
[No Abstract] [Full Text] [Related]
5. Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors: a randomized clinical trial.
Ikeda Y; Shimada K; Teramoto T; Uchiyama S; Yamazaki T; Oikawa S; Sugawara M; Ando K; Murata M; Yokoyama K; Ishizuka N
JAMA; 2014 Dec; 312(23):2510-20. PubMed ID: 25401325
[TBL] [Abstract][Full Text] [Related]
6. Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial.
Sesso HD; Buring JE; Christen WG; Kurth T; Belanger C; MacFadyen J; Bubes V; Manson JE; Glynn RJ; Gaziano JM
JAMA; 2008 Nov; 300(18):2123-33. PubMed ID: 18997197
[TBL] [Abstract][Full Text] [Related]
7. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.
Ridker PM; Cook NR; Lee IM; Gordon D; Gaziano JM; Manson JE; Hennekens CH; Buring JE
N Engl J Med; 2005 Mar; 352(13):1293-304. PubMed ID: 15753114
[TBL] [Abstract][Full Text] [Related]
8. Aspirin for the Primary Prevention of Cardiovascular Events: A Systematic Evidence Review for the U.S. Preventive Services Task Force.
Guirguis-Blake JM; Evans CV; Senger CA; O'Connor EA; Whitlock EP
Ann Intern Med; 2016 Jun; 164(12):804-13. PubMed ID: 27064410
[TBL] [Abstract][Full Text] [Related]
9. Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: 10-Year Follow-Up of a Randomized Controlled Trial.
Saito Y; Okada S; Ogawa H; Soejima H; Sakuma M; Nakayama M; Doi N; Jinnouchi H; Waki M; Masuda I; Morimoto T;
Circulation; 2017 Feb; 135(7):659-670. PubMed ID: 27881565
[TBL] [Abstract][Full Text] [Related]
10. Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial.
Lee IM; Cook NR; Gaziano JM; Gordon D; Ridker PM; Manson JE; Hennekens CH; Buring JE
JAMA; 2005 Jul; 294(1):56-65. PubMed ID: 15998891
[TBL] [Abstract][Full Text] [Related]
11. Aspirin and primary cardiovascular prevention. Uncertain balance between benefits and risks.
Prescrire Int; 2010 Nov; 19(110):258-61. PubMed ID: 21284360
[TBL] [Abstract][Full Text] [Related]
12. Famotidine for the prevention of peptic ulcers and oesophagitis in patients taking low-dose aspirin (FAMOUS): a phase III, randomised, double-blind, placebo-controlled trial.
Taha AS; McCloskey C; Prasad R; Bezlyak V
Lancet; 2009 Jul; 374(9684):119-25. PubMed ID: 19577798
[TBL] [Abstract][Full Text] [Related]
13. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
De Schryver EL; Algra A; van Gijn J
Cochrane Database Syst Rev; 2003; (1):CD001820. PubMed ID: 12535415
[TBL] [Abstract][Full Text] [Related]
14. Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial.
Mehta SR; Tanguay JF; Eikelboom JW; Jolly SS; Joyner CD; Granger CB; Faxon DP; Rupprecht HJ; Budaj A; Avezum A; Widimsky P; Steg PG; Bassand JP; Montalescot G; Macaya C; Di Pasquale G; Niemela K; Ajani AE; White HD; Chrolavicius S; Gao P; Fox KA; Yusuf S;
Lancet; 2010 Oct; 376(9748):1233-43. PubMed ID: 20817281
[TBL] [Abstract][Full Text] [Related]
15. Low-dose aspirin for primary prevention of cardiovascular disease.
Bredie SJ; Wollersheim H; Verheugt FW; Thien T
Semin Vasc Med; 2003 May; 3(2):177-84. PubMed ID: 15199480
[TBL] [Abstract][Full Text] [Related]
16. Aspirin therapy and primary prevention of cardiovascular disease in diabetes mellitus.
Younis N; Williams S; Soran H
Diabetes Obes Metab; 2009 Nov; 11(11):997-1000. PubMed ID: 19531055
[TBL] [Abstract][Full Text] [Related]
17. Baseline characteristics of participants in the Women's Health Study.
Rexrode KM; Lee IM; Cook NR; Hennekens CH; Buring JE
J Womens Health Gend Based Med; 2000; 9(1):19-27. PubMed ID: 10718501
[TBL] [Abstract][Full Text] [Related]
18. Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. The Medical Research Council's General Practice Research Framework.
Lancet; 1998 Jan; 351(9098):233-41. PubMed ID: 9457092
[TBL] [Abstract][Full Text] [Related]
19. A randomized trial of low-dose aspirin in the prevention of clinical type 2 diabetes in women.
Pradhan AD; Cook NR; Manson JE; Ridker PM; Buring JE
Diabetes Care; 2009 Jan; 32(1):3-8. PubMed ID: 18835953
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
